Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of the fiscal period ended Monday, September 30, 2024.
Reported annual fiscal-period values; no daily interpolation.
PEG RATIO
N/A
PEG RATIO AVG TTM
N/A
PEG RATIO AVG 3Y
0.22
PEG RATIO AVG 5Y
1.94
PEG RATIO AVG 10Y
1.02
PEG RATIO AVG 15Y
0.93
PEG RATIO AVG 20Y
0.30
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PEG RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | $16.97B | N/A | N/A | 0.22 | 1.94 |
| Medpace Holdings, Inc. (MEDP)vs › | $16.79B | 1.82 | 1.22 | 1.14 | 1.18 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.67B | N/A | 0.07 | 1.03 | 0.84 |
| DaVita Inc. (DVA)vs › | $15.11B | 2.87 | 0.38 | 0.35 | 0.56 |
| Viatris Inc. (VTRS)vs › | $20.08B | N/A | 0.02 | 1.20 | 0.80 |
| The Cooper Companies, Inc. (COO)vs › | $13.71B | N/A | 1.65 | 0.82 | 0.56 |
| Solventum Corporation (SOLV)vs › | $13.51B | 0.04 | 0.04 | 117.61 | 78.52 |
| STERIS plc (STE)vs › | $20.86B | 1.03 | 0.80 | 0.61 | 0.61 |
| Moderna, Inc. (MRNA)vs › | $21.45B | N/A | 0.18 | 0.14 | 0.14 |
| Revvity, Inc. (RVTY)vs › | $12.32B | N/A | 0.95 | 0.69 | 0.60 |
PEG Ratio
N/A
P/E Ratio
31.7
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PEG RATIO |
|---|---|
| 2024-09-30 | 0.30 |
| 2021-09-30 | 0.14 |
| 2019-09-30 | 5.39 |
| 2018-09-30 | 0.89 |
| 2017-09-30 | 0.11 |
| 2016-09-30 | 0.22 |
| 2015-09-30 | 0.12 |
| 2012-09-30 | 0.50 |
| 2010-09-30 | 0.69 |
| 2008-09-30 | 0.04 |
| 2007-09-30 | 0.18 |
| 2005-09-30 | 0.36 |
| 2004-09-30 | 0.11 |
| 2003-09-30 | 0.06 |
| 1999-09-30 | 0.12 |
| 1997-09-30 | 0.50 |
| 1996-09-30 | 0.08 |